Trial of the Reactogenicity, Safety and Immunogenicity of the Flu-M Vaccine Manufactured by FSUE SPbSRIVS FMBA

NCT05297994 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
400
Enrollment
OTHER_GOV
Sponsor class

Conditions

Interventions

Sponsor

St. Petersburg Research Institute of Vaccines and Sera